Tag | Content |
---|
EnhancerAtlas ID | HS161-06745 |
Organism | Homo sapiens |
Tissue/cell | PC3 |
Coordinate | chr17:43545960-43548270 |
Target genes | Number: 16 | Name | Ensembl ID |
|
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
CDX2 | MA0465.1 | chr17:43547718-43547729 | AAGCAATAAAA | + | 6.32 | KLF4 | MA0039.3 | chr17:43546069-43546080 | CCACACCCTCT | + | 6.02 | TFAP2C | MA0524.2 | chr17:43546390-43546402 | TGCCCTGGGGCA | + | 6.44 | TFAP2C | MA0524.2 | chr17:43546390-43546402 | TGCCCTGGGGCA | - | 7.22 |
|
| Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
SE_23758 | chr17:43545077-43547281 | Colon_Crypt_2 | SE_33869 | chr17:43544899-43547867 | HCC1954 | SE_42602 | chr17:43545143-43547105 | Lung | SE_57681 | chr17:43545171-43547207 | VACO_503 | SE_58107 | chr17:43546078-43546864 | VACO_9m |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr17 | 43546334 | 43546575 | chr17 | 43546824 | 43546894 |
|
| Number: 2 | ID | Chromosome | Start | End |
GH17I045468 | chr17 | 43545821 | 43545970 | GH17I045469 | chr17 | 43546079 | 43546864 |
|
Enhancer Sequence | TAGAAGTTTT AAACAAAGAA ACCTGTGTGA CAGGTTGTCT GCGATAATGC CCAAGGCAAC 60 TGGGGCAGAG GGAAGAATGC AAAACTGCTG TTTTATGATT TAAAACAACC CACACCCTCT 120 AAATGATCCA CTGCACTCCC CCTCACGCAG TCCTCCTCTG ACACTCCCAC CACGTTTTTC 180 CTGGCCAGGA TTTAGGCAGA CTGCGTGGAC AGGTGATTTG TGGAGCCTGG GATCTCAGGC 240 GAAAAAGCTC CCCAGCAGAG GAAGAGGACT TGGTATGAAT GAGGACTTAC TGGCATTCTG 300 AGCAGGCTAG CTGTGGGCCT GGAGAGCTTG CTCAGCCAAA CACATGGTTG TGTGGGCAAT 360 CGTTTCCCCA AACATGGTAT GCAGCAGAGC CTCCTCCTCC ACAGCACAGG GAGTAGAGAT 420 GCCAGGACTC TGCCCTGGGG CAGGGACTAG GAGAAGCGAG GGCTAGGCAG GTTTCCTAAG 480 CAAGGTCATA CTTTGTTCCT GTGCAGGCAC TGGGACAGCA AGGGGAGGTG CAAGGGCTGG 540 TCCCCTCAGA GCTGGACTGG ATGTGGAGAC AGAGAAGCTT CACATCCCCA GAAACTGCTG 600 CTGGAGCTCA ATGTATACCA GGTGTGTGAG GGTGGATATG AGTACACACG AGATGTGCCC 660 CTGCTCACTC TCTATGGTGG GACTGCCACT CCCTGTCTCC TCCGTGCTGC TTCCTGGGGC 720 CACAGGGAGC AAATGTTACT GCCTTGGTAC ACGTGCATGC ACACCACACT CACACATACA 780 CACTGCACAG AAACATGCCC TGGGCCCTCT GGAATGTGCA CTGACTAGCA ACTGCTCCTC 840 CCTCTCCTGA GGCTTCTTCT GAGGATCCAA GCTCCATTTT GAAAATAAAC CCGTTTGCTA 900 TCTCTTCTGC TTATAAAACC AGTGGAGCAT GTCATGGGCA AAGCCTGGTT CAGGTGGCCA 960 CAGGCTGTCT AAGGCCCCAA AGCCTCCCTG CATCTGCCCT GATGGCTTGG ACTGGGTCCA 1020 GAAGATACAT GAAGCTCTGC TTAATTTGGG CTTAGGGAAA TGAGGATTTT AGAATTCAAG 1080 TTGCTTACCT GATTGTCTTT CCAGTGAGCT CTGCACCATC TTAACCCCAA ACAACATTTC 1140 AAGACATTAT GGTCAAGAAT AGGTGGCCAA TCCATACATG TATAAGTAAC TGATTTTGGC 1200 CGGGTGTGGT GGCTCACATC TGCAATCCCA GCACTTTGGG AGGCTGAGGT GGGTAGAACC 1260 ACAAGATCAG GAGTTCAAGA CTAGCATGGC CAAGATGGTA AAACCCCGTC TCTACTAAAA 1320 ATACAAAAAT TAGCCAGGCT TGGTGGCAGG CGCCTGTAAT CCCAGCTACT CAGGAGGCTG 1380 AGGCAGAGAA TTGCTTGAAC CCGGAAGGTG GAGGTTGCAG TGAGCCGAGA TTGTGCCACT 1440 GCAATCCAGC CTGGGTGAAA GAGCGAGACT CCATCTCAAA AAAAAAAAGA GTAACTGATT 1500 TTCAACATAG ACACCAACAC ATTTTAATGG GGAGGGAATA GTCTTTTCAA CAATTGTGCT 1560 GAGATAAGTG GATAATCACA TGCAAAAGAA AAAAGCTGGA CTGCTATCTC ACATTGTATA 1620 CAAAAATTAA CTCAAAGTGG ATTAAAGACC TAAAGGTAAG AGCTAAAACT GTAAAACTCT 1680 TAGAAGGAAA GAGAGGTATA AACTTCATGT CTTTGGATTA GGCAATGGTT TCTTAGATGT 1740 GAGATCTACA GCATAAGAAA GCAATAAAAA ATAAATTGTA ATCCCAGCAC TTTGGAGGCC 1800 AAGGCGGGTG GATCACCTGA GGCCAGGAGT TCGAGATCAG CCTGGCCAAC ATAGTGAAAC 1860 CCTGTTTCTA ATAAAAATAC AAAAATTAGT TGGGCGTGGT GGTGCGCACC TGTAATCCCA 1920 GCTACTTGGG GGGCTAAGGC AGGAGAATCA CTTGAACCCG GGACGGGGAG GCTGCAGTGA 1980 GCCGAGATCA CACCACTGCA CTCCAGCCTG GGCAACAAAG TGAAACTCTG TTTCAAAAAA 2040 CAAAAATAAA AAACGTTTGT GTGGTTTTTT TTTTTTTTAT TTGAGACTGA GTCTCACTCT 2100 GTCGCCCAGG CTGGAGTGCA GTGGCGCCAT CTCGGCTCAC TGCAAGCTCC GCCTCCCGGG 2160 TTCATGCCAT TCTCCTGCCT CAGACTCCCG ATTAGCTAGG ACTACAGACG CCCGCCACAA 2220 CGCCCAGCTA ATTTTTTGTA TTGTTTTTTT TTTAGTAGAG ATGGAGTTTC ACCGTTTTAA 2280 CCAGGATGGT CTCGATCTCC TGACCTCGTG 2310
|